Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone in AF with Left Atrial Enlargement
NCT01198873Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Sep 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Dronedarone with Placebo (2 arms). Primary endpoint: Change From Baseline in Left Atrial Volume Index. Started Sep 2010; status: terminated.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01198873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198873.